190 Chapter 8 R, Roy K. The changing nature of HPV associated with high grade cervical lesions in vaccinated populations, a retrospective study of over 1700 cases in Scotland. Br J Cancer 2023. 93. Leeman A, Ebisch RMF, Kasius A, Bosgraaf RP, Jenkins D, van de Sandt MM, et al. Defining hrHPV genotypes in cervical intraepithelial neoplasia by laser capture microdissection supports reflex triage of self-samples using HPV16/18 and FAM19A4/miR124-2 methylation. Gynecol Oncol 2018; 151(2): 311-8. 94. Wever BMM, van den Helder R, van Splunter AP, van Gent M, Kasius JC, Trum JW, et al. DNA methylation testing for endometrial cancer detection in urine, cervicovaginal self-samples and cervical scrapes. Int J Cancer 2023; 153(2): 341-51. 95. Rausch S, Hasinger O, König T, Schlegel A, Weiss G. An automated high throughput solution for DNA extraction and bisulfiteconversion from high volume liquid biopsy specimens: sample preparation for epigenetic analysis. BMC Res Notes 2019; 12(1): 551. 96. Hawkes D, Keung MHT, Huang Y, McDermott TL, Romano J, Saville M, et al. Self-Collection for Cervical Screening Programs: From Research to Reality. Cancers (Basel) 2020; 12(4). 97. Rodems TS, Juang DS, Stahlfeld CN, Gilsdorf CS, Krueger TEG, Heninger E, et al. SEEMLIS: a flexible semi-automated method for enrichment of methylated DNA from low-input samples. Clin Epigenetics 2022; 14(1): 37. 98. Bendixen KK, Mindegaard M, Epistolio S, Dazio G, Marchi F, Spina P, et al. A qPCR technology for direct quantification of methylation in untreated DNA. Nat Commun 2023; 14(1): 5153. 99. Aitken CA, Kaljouw S, Siebers AG, Bron M, Morssink A, van Kemenade FJ, et al. Investigating the decrease in participation in the Dutch cervical cancer screening programme: The role of personal and organisational characteristics. Prev Med Rep 2021; 22: 101328. 100. Chaw L, Lee SHF, Ja’afar NIH, Lim E, Sharbawi R. Reasons for non-attendance to cervical cancer screening and acceptability of HPV self-sampling among Bruneian women: A cross-sectional study. PLoS One 2022; 17(3): e0262213. 101. Nishimura H, Yeh PT, Oguntade H, Kennedy CE, Narasimhan M. HPV self-sampling for cervical cancer screening: a systematic review of values and preferences. BMJ Glob Health 2021; 6(5). 102. Yeh PT, Kennedy CE, de Vuyst H, Narasimhan M. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob Health 2019; 4(3): e001351. 103. van den Helder R, Steenbergen RDM, van Splunter AP, Mom CH, Tjiong MY, Martin I, et al. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection. Clin Cancer Res 2022; 28(10): 2061-8. 104. van den Helder R, van Trommel NE, van Splunter AP, Lissenberg-Witte BI, Bleeker MCG, Steenbergen RDM. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection. Papillomavirus Res 2020; 9: 100193. 105. Snoek BC, Splunter APV, Bleeker MCG, Ruiten MCV, Heideman DAM, Rurup WF, et al. Cervical cancer detection by DNA methylation analysis in urine. Sci Rep 2019; 9(1): 3088. 106. Van Keer S, van Splunter AP, Pattyn J, De Smet A, Herzog SA, Van Ostade X, et al. Triage of human papillomavirus infected women by methylation analysis in firstvoid urine. Sci Rep 2021; 11(1): 7862. 107. Guerrero-Preston R, Valle BL, Jedlicka A, Turaga N, Folawiyo O, Pirini F, et al. Molecular Triage of Premalignant Lesions in Liquid-Based Cervical Cytology and Circulating Cell-Free DNA from Urine, Using a Panel of Methylated Human Papilloma Virus and Host Genes. Cancer Prev Res (Phila) 2016; 9(12): 915-24.
RkJQdWJsaXNoZXIy MjY0ODMw